Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium While mutations in the ESR1 gene are exceedingly rare in cancer patients prior to treatment, the use of endocrine ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ...

Mutations are the fundamental source of genetic variation but also the cause of deleterious effects on fitness. The mutation rate (the number of genetic changes within a given unit of time) is a ...

A new long-read sequencing technique has helped researchers investigate how DNA mutations arise in a variety of contexts. A collaboration of researchers led by NYU Langone Health and NYU Grossman ...

Acute myeloid leukemia (AML) has a dismal prognosis, with a 5 year overall survival of ~30% [1]. The poor outcomes are in part due to AML being a heterogeneous disease, with substantial variability ...

Bio-Techne Corp. (TECH Quick Quote TECH - Free Report) has launched a highly sensitive ESR1 mutation monitoring assay through its Asuragen brand. ESR1 gene mutations are known to be linked to hormone ...